Dr. Peter J. Kneuertz is a thoracic surgeon at the James Comprehensive Cancer Center in Columbus, Ohio, specializing in minimally invasive surgery for the treatment of lung cancer, esophageal cancer, and other thoracic malignancies, including pleural mesothelioma. He is skilled in Video-Assisted Thoracoscopic Surgery (VATS) and robotic surgery, as well as extrapleural pneumonectomy and bronchoscopy.
Dr. Robert E. Merritt is a general thoracic surgeon, professor, and director of the Division of Thoracic Surgery at Ohio State University. He has special expertise in minimally invasive surgery in the treatment of lung cancer and thoracic malignancies, including pleural mesothelioma. His clinical interests include primary lung carcinoma, esophageal carcinoma, thymic malignancies, primary tumors
Dr. Philip Linden is the Chief of the Division of Thoracic and Esophageal Surgery at University Hospitals and UH Seidman Cancer Center in Cleveland, Ohio. His clinical interests are thoracic cancers of all kinds, including lung cancer and pleural mesothelioma, and he is skilled in ablative therapies and minimally invasive lung and esophageal surgeries, including
Dr. Afshin Dowlati is a medical oncologist and hematologist at the University Hospitals Seidman Cancer Center and a researcher at Case Comprehensive Cancer Center. As the Director of the Thoracic Oncology Program, he specializes in both the biological and clinical management of thoracic malignancies, with a particular interest in small cell lung cancer and pleural
Dr. Melinda Hsu is a thoracic medical oncologist at University Hospitals Seidman Cancer Center and an Assistant Professor of Medicine at Case Western Reserve University. She specializes in the care of patients with lung cancer, as well as other thoracic malignancies, including malignant pleural mesothelioma. Education and Career Dr. Hsu earned her Bachelor of Arts
Dr. Debora S. Bruno is a thoracic medical oncologist and Medical Director of Clinical Research at the City of Hope in Atlanta, Georgia. She is focused on caring for patients with lung cancer, thymic malignancies, and malignant pleural mesothelioma, with an emphasis on the use of new therapies that improve the time patients have without
Dr. Jared Weiss is a medical oncologist and the Section Chief of Thoracic and Head/Neck Oncology at the UNC School of Medicine and the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina. He specializes in lung cancer, squamous head and neck cancer, and other cancers, including pleural mesothelioma, with a focus on the
Dr. Chad Pecot is a thoracic medical oncologist and physician-scientist at the University of North Carolina and Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina. He specializes in lung cancer and abnormal tumors inside the chest, including pleural mesothelioma. As a former cancer patient, he strives to rapidly bring research innovations into clinical practice.
Dr. Carrie Lee is a medical and thoracic oncologist at the University of North Carolina at Chapel Hill and a Professor at the UNC School of Medicine. Her clinical practice focuses on lung cancer, and she has experience with traditional chemotherapy protocols as well as novel regimens. She is also the Chief Medical Officer for UNC
A just-released study conducted in the Netherlands provides a mixed assessment of the use of nivolumab-ipilimumab immunotherapy in patients with malignant pleural mesothelioma. While researchers found that the real-world efficacy of the combination was comparable to what was reported in a phase 3 study, they also reported that toxicities – particularly among elderly patients –